- Home
- RPRX vs OWL Comparison
RPRX vs OWL Comparison
Compare RPRX & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- OWL
- Stock Information
- Founded
- RPRX 1996
- OWL 2020
- Country
- RPRX United States
- OWL United States
- Employees
- RPRX N/A
- OWL N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- OWL Investment Managers
- Sector
- RPRX Health Care
- OWL Finance
- Exchange
- RPRX Nasdaq
- OWL Nasdaq
- Market Cap
- RPRX 13.9B
- OWL 11.6B
- IPO Year
- RPRX 2020
- OWL N/A
- Fundamental
- Price
- RPRX $33.58
- OWL $19.07
- Analyst Decision
- RPRX Strong Buy
- OWL Buy
- Analyst Count
- RPRX 3
- OWL 15
- Target Price
- RPRX $47.33
- OWL $24.10
- AVG Volume (30 Days)
- RPRX 5.5M
- OWL 7.9M
- Earning Date
- RPRX 05-08-2025
- OWL 07-31-2025
- Dividend Yield
- RPRX 2.62%
- OWL 4.72%
- EPS Growth
- RPRX 37.60
- OWL 23.81
- EPS
- RPRX 2.45
- OWL 0.16
- Revenue
- RPRX $2,263,845,000.00
- OWL $2,465,573,000.00
- Revenue This Year
- RPRX $29.35
- OWL $19.37
- Revenue Next Year
- RPRX $7.58
- OWL $22.48
- P/E Ratio
- RPRX $13.70
- OWL $120.98
- Revenue Growth
- RPRX 1.13
- OWL 32.99
- 52 Week Low
- RPRX $24.05
- OWL $14.55
- 52 Week High
- RPRX $34.32
- OWL $26.73
- Technical
- Relative Strength Index (RSI)
- RPRX 56.69
- OWL 53.42
- Support Level
- RPRX $33.37
- OWL $18.18
- Resistance Level
- RPRX $33.97
- OWL $19.47
- Average True Range (ATR)
- RPRX 0.53
- OWL 0.46
- MACD
- RPRX 0.05
- OWL 0.04
- Stochastic Oscillator
- RPRX 76.06
- OWL 76.88
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.